Takeda, Merck invest in Waltham cancer startup's $100M round

A cancer biotech backed by Atlas Venture and F-Prime Capital has drawn the attention of some of the biggest names in oncology drugs and tripled its cash in a new financing round.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.